Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a study titled ‘Prospective ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 clinical study titled ‘A Phase 3, ...

Large cohort study finds TNF inhibitors linked to lower cancer risk in psoriasis, supporting long-term safety of biologic ...

A David Geffen School of Medicine at UCLA-led research team reports that vitiligo is associated with increased depression risk, with higher risk among Black and Hispanic patients.

APREMILAST demonstrated sustained efficacy and a consistent safety profile over 52 weeks in paediatric patients with moderate ...

A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab ...